Skip to main content

SHUAA Capital

By Rachel McArthur | 09:50 am | October 21, 2021
The pharma-technology company has just secured $34.8 million in Series C funding, in a combination of equity and debt financing led by Abu Dhabi’s DisruptAD, and the Dubai-headquartered SHUAA Capital.